… In order to assess whether these findings were related to SARS-CoV-2 infection, we analysed
the control cases with diffuse parenchymal lung diseases as uninfected control specimens …

… pathogenic Cornonavirus for humans after other coronavirus species which are: seasonal
HCoV, SARS-CoV, MERS-CoV [3]. Whereas coronavirus 2 (SARSCoV-2) causes a severe …

… , since it can lead to disease progression, organ failure, ARDS … in the genesis of SARS-CoV-2-induced
lung disease. An overview on … vaccines against SARS-CoV-2 has been included. …

… of cytokine storm in SARS-CoV-2 pulmonary disease. NETs are responsible for the
interplay between inflammation and thrombosis in the affected lungs. The immunothrombosis, …

… lungs to identify molecular characteristics of lung … lung diseases. We observe a similar
cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. …

… to SAR-CoV-2 infection. Our preliminary study also suggests that many patients with
persistent ILD have diffuse fibrotic lung disease that likely precedes SARS-CoV-2 infection. …

… CT (HRCT) findings in SARS-CoV-2-related ARDS survivors … from April to September 2020
for SARS-CoV-2-related ARDS, … and classified according to lung segmental distribution. The …

We describe an ex-premature infant presenting with severe acute respiratory syndrome
coronavirus 2 infection in the fifth week of life. In current reports, researchers indicate that acute …

… role in health deterioration and diseases, particularly those targeting the lung (2), is …
coronavirus 2 (SARS-CoV-2)–induced lung disease, including the development of long-lasting lung …

… diseases, particularly chronic obstructive pulmonary disease (COPD) and asthma, would be
at increased risk of SARS-CoV-… However, it is striking that both diseases appear to be under-…